Albany, New York (PRWEB) April 18, 2013
TechNavio’s analysts forecast the Global Neurostimulation Devices market to grow at a CAGR of 15.3 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of neurological disorders. The Global Neurostimulation Devices market has also been witnessing an increasing demand for minimally invasive procedures to treat neurological disorders. However, the availability of alternative drug therapy could pose a challenge to the growth of this market.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis/166445
TechNavio’s report, Global Neurostimulation Devices Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it covers the Global Neurostimulation Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space are Medtronic Inc., St. Jude Medical Inc., Boston Scientific Corp., and Cyberonics Inc.
The other vendors mentioned in the report are Afferent Corp., Cyberkinetics Neurotechnology Systems Inc., Synapse Biomedical Inc., SPR Therapeutics LLC, NeuroVista Corp., and Neuros Medical Inc.
Related Report: Neurostimulation Market – Advanced Technologies, Global Market and Industry Analysis, Size, Trends and Forecast, 2012 – 2018 : http://www.marketresearchreports.biz/analysis/152321
Key questions answered in this report: